Skip to content

Tag: Carbapenem resistant enterobacterales

Explore our medication guides and pharmacology articles within this category.

What is a drug in CRE? Understanding Treatment Options for Resistant Bacteria

3 min read
According to the Centers for Disease Control and Prevention (CDC), carbapenem-resistant Enterobacterales (CRE) caused approximately 13,100 infections in U.S. hospital patients in 2017 alone, with about 1,100 deaths. The critical public health threat lies in the fact that these bacteria are resistant to carbapenem antibiotics, making the question of what is a drug in CRE a complex challenge for infectious disease specialists.